# Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/promoter-methylation-of-brca1-in-triple-negative-breast-cancer-predicts/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ye Xu,Limei Diao,yu-ao Chen,Yiqiang Liu,C. Wang,Tao Ouyang,J. Li,T. Wang,Zhaoqing Fan,Tao Fan,Bo Lin,Dajun Deng,Steven A. Narod,Yuxin Xie |
| Citations | 102 |
| DOI | 10.1093/annonc/mdt011 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.annalsofoncology.org/article/S0923753419372989/pdf |
| OpenAlex ID | https://openalex.org/W2149160061 |
| PMID | 23406733 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Ye Xu](https://scholariq.org/researchers/ye-xu/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)

## Paper topics

- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.